Experiment: 2MTI

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.5 mM [U-100% 13C; U-100% 15N] NKR-P1A, 15 mM PIPES, 50 mM sodium chloride, 1 mM sodium azide, 90 % H2O, 10 % D2O	90% H2O/10% D2O		6.8	1 atm	303
2	2D 1H-13C HSQC aliphatic	0.5 mM [U-100% 13C; U-100% 15N] NKR-P1A, 15 mM PIPES, 50 mM sodium chloride, 1 mM sodium azide, 90 % H2O, 10 % D2O	90% H2O/10% D2O		6.8	1 atm	303
3	3D CBCA(CO)NH	0.5 mM [U-100% 13C; U-100% 15N] NKR-P1A, 15 mM PIPES, 50 mM sodium chloride, 1 mM sodium azide, 90 % H2O, 10 % D2O	90% H2O/10% D2O		6.8	1 atm	303
4	3D HNCACB	0.5 mM [U-100% 13C; U-100% 15N] NKR-P1A, 15 mM PIPES, 50 mM sodium chloride, 1 mM sodium azide, 90 % H2O, 10 % D2O	90% H2O/10% D2O		6.8	1 atm	303
5	3D HNCA	0.5 mM [U-100% 13C; U-100% 15N] NKR-P1A, 15 mM PIPES, 50 mM sodium chloride, 1 mM sodium azide, 90 % H2O, 10 % D2O	90% H2O/10% D2O		6.8	1 atm	303
6	3D HN(CO)CA	0.5 mM [U-100% 13C; U-100% 15N] NKR-P1A, 15 mM PIPES, 50 mM sodium chloride, 1 mM sodium azide, 90 % H2O, 10 % D2O	90% H2O/10% D2O		6.8	1 atm	303
7	3D HNCO	0.5 mM [U-100% 13C; U-100% 15N] NKR-P1A, 15 mM PIPES, 50 mM sodium chloride, 1 mM sodium azide, 90 % H2O, 10 % D2O	90% H2O/10% D2O		6.8	1 atm	303
8	3D HN(CA)CO	0.5 mM [U-100% 13C; U-100% 15N] NKR-P1A, 15 mM PIPES, 50 mM sodium chloride, 1 mM sodium azide, 90 % H2O, 10 % D2O	90% H2O/10% D2O		6.8	1 atm	303
9	3D H(CCO)NH	0.5 mM [U-100% 13C; U-100% 15N] NKR-P1A, 15 mM PIPES, 50 mM sodium chloride, 1 mM sodium azide, 90 % H2O, 10 % D2O	90% H2O/10% D2O		6.8	1 atm	303
10	3D H(CCO)NH	0.5 mM [U-100% 13C; U-100% 15N] NKR-P1A, 15 mM PIPES, 50 mM sodium chloride, 1 mM sodium azide, 90 % H2O, 10 % D2O	90% H2O/10% D2O		6.8	1 atm	303
11	3D HCCH-TOCSY aliphatic	0.5 mM [U-100% 13C; U-100% 15N] NKR-P1A, 15 mM PIPES, 50 mM sodium chloride, 1 mM sodium azide, 90 % H2O, 10 % D2O	90% H2O/10% D2O		6.8	1 atm	303
12	3D 1H-15N NOESY	0.5 mM [U-100% 13C; U-100% 15N] NKR-P1A, 15 mM PIPES, 50 mM sodium chloride, 1 mM sodium azide, 90 % H2O, 10 % D2O	90% H2O/10% D2O		6.8	1 atm	303
13	2D 1H-13C HSQC aromatic	0.5 mM [U-100% 13C; U-100% 15N] NKR-P1A, 15 mM PIPES, 50 mM sodium chloride, 1 mM sodium azide, 90 % H2O, 10 % D2O	90% H2O/10% D2O		6.8	1 atm	303
14	3D HCCH-TOCSY aromatic	0.5 mM [U-100% 13C; U-100% 15N] NKR-P1A, 15 mM PIPES, 50 mM sodium chloride, 1 mM sodium azide, 90 % H2O, 10 % D2O	90% H2O/10% D2O		6.8	1 atm	303
15	2D (HB)CB(CGCD)HD	0.5 mM [U-100% 13C; U-100% 15N] NKR-P1A, 15 mM PIPES, 50 mM sodium chloride, 1 mM sodium azide, 90 % H2O, 10 % D2O	90% H2O/10% D2O		6.8	1 atm	303
16	3D 1H-13C NOESY aliphatic	0.5 mM [U-100% 13C; U-100% 15N] NKR-P1A, 15 mM PIPES, 50 mM sodium chloride, 1 mM sodium azide, 90 % H2O, 10 % D2O	90% H2O/10% D2O		6.8	1 atm	303
17	3D 1H-13C NOESY aromatic	0.5 mM [U-100% 13C; U-100% 15N] NKR-P1A, 15 mM PIPES, 50 mM sodium chloride, 1 mM sodium azide, 90 % H2O, 10 % D2O	90% H2O/10% D2O		6.8	1 atm	303

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	600

NMR Refinement
Method	Details	Software
simulated annealing		TopSpin

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	10
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	TopSpin	2.3.6	Bruker Biospin
2	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
3	chemical shift assignment	Sparky	3.113	Goddard
4	data analysis	Sparky	3.113	Goddard
5	peak picking	Sparky	3.113	Goddard
6	structure solution	ARIA	2.3.1	Linge, O'Donoghue and Nilges
7	structure solution	CNS	1.21	Brunger, Adams, Clore, Gros, Nilges and Read
8	refinement	RECOORD		Brunger, Adams, Clore, Gros, Nilges and Read
9	validation	CING		(CING) Vuister, Doreleijer, da Silva

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.